• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Acceleron Pharma, Inc. (XLRN)

    -NasdaqGM
    25.41 Up 0.58(2.34%) 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 14,632   57,230   15,254  
    Cost of Revenue -   -   -  
    Gross Profit 14,632   57,230   15,254  
    Operating Expenses
    Research Development50,897  36,051  35,319  
    Selling General and Administrative14,199  14,227  8,824  
    Non Recurring5,000   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (55,464) 6,952   (28,889)
    Income from Continuing Operations
    Total Other Income/Expenses Net5,127  (26,758)(2,164)
    Earnings Before Interest And Taxes(50,337)(19,806)(31,053)
    Interest Expense922  2,092  1,529  
    Income Before Tax(51,259)(21,898)(32,582)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(51,259)(21,898)(32,582)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (51,259) (21,898) (32,582)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (51,259) (21,898) (32,582)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.